Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study
Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics...
Saved in:
| Published in | International journal of medical sciences Vol. 18; no. 16; pp. 3624 - 3630 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Australia
Ivyspring International Publisher Pty Ltd
01.01.2021
Ivyspring International Publisher |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1449-1907 1449-1907 |
| DOI | 10.7150/ijms.64458 |
Cover
| Abstract | Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on
F-fluorodeoxyglucose (
F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD).
A total of 22 adults with biopsy-confirmed MAFLD, who underwent
F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in
F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis.
The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis.
These preliminary data suggest that
F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD. |
|---|---|
| AbstractList | Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD.Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD. Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on F-fluorodeoxyglucose ( F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). A total of 22 adults with biopsy-confirmed MAFLD, who underwent F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. These preliminary data suggest that F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD. Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore the diagnostic capabilities of other non-invasive tests to diagnose low levels of fibrosis. We aimed to evaluate the performance of radiomics based on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in predicting any liver fibrosis in individuals with biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: A total of 22 adults with biopsy-confirmed MAFLD, who underwent 18F-FDG PET/CT, were enrolled in this study. Sixty radiomics features were extracted from whole liver region of interest in 18F-FDG PET images. Subsequently, the minimum redundancy maximum relevance (mRMR) method was performed and a subset of two features mostly related to the output classes and low redundancy between them were selected according to an event per variable of 5. Logistic regression, Support Vector Machine, Naive Bayes, 5-Nearest Neighbor and linear discriminant analysis models were built based on selected features. The predictive performances were assessed by the receiver operator characteristic (ROC) curve analysis. Results: The mean (SD) age of the subjects was 38.5 (10.4) years and 17 subjects were men. 12 subjects had histological evidence of any liver fibrosis. The coarseness of neighborhood grey-level difference matrix (NGLDM) and long-run emphasis (LRE) of grey-level run length matrix (GLRLM) were selected to predict fibrosis. The logistic regression model performed best with an AUROC of 0.817 [95% confidence intervals, 0.595-0.947] for prediction of liver fibrosis. Conclusion: These preliminary data suggest that 18F-FDG PET radiomics may have clinical utility in assessing early liver fibrosis in MAFLD. |
| Author | Chen, Yang-Zong Huang, Ou-Yang Zheng, Ming-Hua Li, Gang Tang, Liang-Jie Tang, Kun Zheng, Xiang-Wu Targher, Giovanni Chen, Zhong-Wei Zhao, You-Fan Wang, Xiao-Dong Byrne, Christopher D. |
| AuthorAffiliation | 4 Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China 5 Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy 3 NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 7 Institute of Hepatology, Wenzhou Medical University, Wenzhou, China 1 Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 2 Department of Nuclear Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 6 Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK |
| AuthorAffiliation_xml | – name: 4 Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China – name: 5 Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy – name: 3 NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China – name: 2 Department of Nuclear Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China – name: 1 Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China – name: 7 Institute of Hepatology, Wenzhou Medical University, Wenzhou, China – name: 6 Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK |
| Author_xml | – sequence: 1 givenname: Zhong-Wei surname: Chen fullname: Chen, Zhong-Wei – sequence: 2 givenname: Kun surname: Tang fullname: Tang, Kun – sequence: 3 givenname: You-Fan surname: Zhao fullname: Zhao, You-Fan – sequence: 4 givenname: Yang-Zong surname: Chen fullname: Chen, Yang-Zong – sequence: 5 givenname: Liang-Jie surname: Tang fullname: Tang, Liang-Jie – sequence: 6 givenname: Gang surname: Li fullname: Li, Gang – sequence: 7 givenname: Ou-Yang surname: Huang fullname: Huang, Ou-Yang – sequence: 8 givenname: Xiao-Dong surname: Wang fullname: Wang, Xiao-Dong – sequence: 9 givenname: Giovanni surname: Targher fullname: Targher, Giovanni – sequence: 10 givenname: Christopher D. surname: Byrne fullname: Byrne, Christopher D. – sequence: 11 givenname: Xiang-Wu surname: Zheng fullname: Zheng, Xiang-Wu – sequence: 12 givenname: Ming-Hua surname: Zheng fullname: Zheng, Ming-Hua |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34790034$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU2LFDEQhoOsuB968QdIwIus9JrupD_iQVhWV4URQfQc0kn1bIZ00ibp0T7uPzfjrLou4ikV6qmXqvc9RgfOO0DocUnO2rImL8xmjGcNY3V3Dx2VjPGi5KQ9uFUfouMYN4TQirblA3RIWcvzjx2h609SGz8aFXEvI2jsHR7s7IMvNPjvy9rOykfAk48mhdyE0cRocpH86NdBTlcLngJoo1LE1mwh4MH0IeMRG4d746e4FFPwW3D4w_nl6vVLLPFkrE84plkvD9H9QdoIj27eE_Tl8s3ni3fF6uPb9xfnq0Ix0qRCc5DQt7xmWndMt43kSkvVlFRpWinayw6A1YQ2lNBB9lzSrtVU1b1m0BBGT9Dzve7sJrl8k9aKKZhRhkWUROyMFDsjxU8jM_1qT09zP4JW4FKQfya8NOLvjjNXYu23oqtbXnGSBZ7dCAT_dYaYRDZOgbXSgZ-jqGqeg6l41Wb06R104-fgshk7qm4aUnU0U09ub_R7lV9ZZuB0D6jsfgww_P8-cgdWJsmUg83XGPuvkR-Ex8SW |
| CitedBy_id | crossref_primary_10_1007_s11307_022_01740_2 crossref_primary_10_1016_j_nucmedbio_2025_108997 crossref_primary_10_3389_fphar_2024_1437479 crossref_primary_10_1186_s12880_024_01272_x crossref_primary_10_7759_cureus_51443 crossref_primary_10_1002_VIW_20240010 |
| ContentType | Journal Article |
| Copyright | The author(s). 2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The author(s) 2021 |
| Copyright_xml | – notice: The author(s). – notice: 2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The author(s) 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
| DOI | 10.7150/ijms.64458 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: Proquest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1449-1907 |
| EndPage | 3630 |
| ExternalDocumentID | 10.7150/ijms.64458 PMC8579290 34790034 10_7150_ijms_64458 |
| Genre | Clinical Trial Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 29J 2WC 4.4 53G 5GY 5VS 7X7 8FI 8FJ AAYXX ABUWG ACGFO ADBBV ADRAZ AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK DU5 E3Z EBS EJD EMOBN F5P FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PUEGO RNS RPM SJN TR2 UKHRP W2D WOQ WOW XSB ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c406t-d9eaeb7954dd84d76a9cdac613cd32c3ba8ee45036303fab9a387d3c5bd4e6043 |
| IEDL.DBID | M48 |
| ISSN | 1449-1907 |
| IngestDate | Sun Oct 26 04:02:47 EDT 2025 Tue Sep 30 16:56:09 EDT 2025 Fri Sep 05 05:29:23 EDT 2025 Tue Oct 07 07:27:00 EDT 2025 Thu Apr 03 06:59:50 EDT 2025 Wed Oct 01 03:28:25 EDT 2025 Thu Apr 24 23:10:51 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 16 |
| Keywords | 18F-FDG PET/CT Metabolic dysfunction-associated fatty liver disease Fibrosis Radiomics |
| Language | English |
| License | The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. cc-by-nc |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c406t-d9eaeb7954dd84d76a9cdac613cd32c3ba8ee45036303fab9a387d3c5bd4e6043 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 Competing Interests: The authors have declared that no competing interest exists. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.7150/ijms.64458 |
| PMID | 34790034 |
| PQID | 2595660283 |
| PQPubID | 5263175 |
| PageCount | 7 |
| ParticipantIDs | unpaywall_primary_10_7150_ijms_64458 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8579290 proquest_miscellaneous_2599072927 proquest_journals_2595660283 pubmed_primary_34790034 crossref_primary_10_7150_ijms_64458 crossref_citationtrail_10_7150_ijms_64458 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Australia |
| PublicationPlace_xml | – name: Australia – name: Wyoming – name: Sydney |
| PublicationTitle | International journal of medical sciences |
| PublicationTitleAlternate | Int J Med Sci |
| PublicationYear | 2021 |
| Publisher | Ivyspring International Publisher Pty Ltd Ivyspring International Publisher |
| Publisher_xml | – name: Ivyspring International Publisher Pty Ltd – name: Ivyspring International Publisher |
| SSID | ssj0032371 |
| Score | 1.9112579 |
| Snippet | Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important to explore... Rationale: Since non-invasive tests for prediction of liver fibrosis have a poor diagnostic performance for detecting low levels of fibrosis, it is important... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 3624 |
| SubjectTerms | Adult Biopsy Blood pressure China Cholesterol Diabetes Discriminant analysis Disease Progression Drug dosages Fatty liver Female Fluorodeoxyglucose F18 Glucose Histology Humans Liver Cirrhosis - diagnosis Liver Cirrhosis - pathology Liver diseases Male Medical imaging Metabolism Middle Aged Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - pathology Performance evaluation Pilot Projects Positron Emission Tomography Computed Tomography - methods Predictive Value of Tests Prognosis Radiometry - methods Radiomics Research Paper Software Tomography Variables |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_qFdQXqd_RKiv2xYfYXL42KxRptUcR75BioW9hs7vBSJqNlxx6j_7nzuSStKXS1-yQLDubmd_OzP4GYC8OjdAii9w4MLGL_nbqJgGVWCHczafSE1LQ3eH5Ij45C7-cR-dbsBjuwlBZ5WATO0OtraIY-T7CdEQe5A0_1r9c6hpF2dWhhYbsWyvog45i7A5s-8SMNYHto-PFt9PBNuMM-HRDUsoRCe0XPy-a94gIqOH7Vbd0A2veLJm8t6pquf4ty_KKP5rtwIMeSLLDjeYfwpapHsHdeZ8qfwx_T6Uu6Mpxw8hTaWYrlpcru7SuNvbPuq9VZ13V1hIHqfEbhc5Yay96HmtWL-l9bcNKKt9gOZ6tUbxhRcWywtbN2qWQhKnY_HD29fMHJlldlLZlHWntEzibHX__dOL2_RZchW69dbUw0mRcRKHWSah5LIXSUqHDVzrwVZDJxJgwotSvF-QyEzJIuA5UlOnQxF4YPIVJZSvzHJjyjc-FQWtgvFArKePck14ecXyY4OZw4N2w3KnqycipJ0aZ4qGEVJOSatJONQ68HWXrDQXHf6V2B62l_W_YpJebxoE34zAuJ2VFZGXsqpMRRJ_ucweebZQ8foau2RKDjwP8mvpHASLnvj5SFT86ku4k4og8PQf2xo1yy-xf3D77l3Dfp1qaLvSzC5N2uTKvEAy12et-h_8DowcQtA priority: 102 providerName: ProQuest – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrQRceD8CBRm1Fw7ZZhMnjrmtKKsKsRVCrFROkWM7IpAm0SYBlRv_nJkku2opAq7xKLEyY89nz8w3AAcRt9LINHSjwEYu-tuZGweUYoVwN5spTypJtcPLk-h4xd-ehqc7sL-phaG0SnQDuP33Yfxvs7jGLZZPa5Ndg90oRMA9gd3Vyfv5p75uiEsXXZoYiEcFopvD_MtZM0UvT03cL7qaK_jxahrkja6s1fl3VRQXfMziNhxtZjeklnyddm061T9-I278x_TvwK0RY7L5YBR3YceW9-D6coyi34efH5TJqRq5YeTEDKtKlhVdta5cY_HTYxo76xO61jhIPeHoVo211dlIcc3qNb2vbVhBmR0sw2M3ijcsL1maV3Vz7tJthS3Zcr54d_SKKVbnRdWyns_2AawWbz6-PnbHVgyuRo_fukZaZVMhQ25MzI2IlNRGacQC2gS-DlIVW8tDigp7QaZSqYJYmECHqeE28njwECZlVdrHwLRvfSEtbhTW40YrFWWe8rJQ4MMY7caBlxutJXrkKad2GUWC5xXScEIaTnoNO7C_la0Hdo4_Su1tlJ-MK7RJ8NiHSJbQlQMvtsP4Oylgokpbdb2MJGZ1XzjwaLCV7WeoApfIfRwQl6xoK0C83ZdHyvxzz98dhwJBqefAwdbe_jL7J_8n9hRu-pRu098O7cGkXXf2GeKlNn0-rpdfMfkcEg priority: 102 providerName: Unpaywall |
| Title | Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34790034 https://www.proquest.com/docview/2595660283 https://www.proquest.com/docview/2599072927 https://pubmed.ncbi.nlm.nih.gov/PMC8579290 https://www.medsci.org/v18p3624.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: KQ8 dateStart: 20040101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: DIK dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: M~E dateStart: 20040101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: RPM dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1449-1907 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1449-1907 dateEnd: 20250731 omitProxy: true ssIdentifier: ssj0032371 issn: 1449-1907 databaseCode: M48 dateStart: 20040301 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db5RAEJ_0I9G-GL-L1ssaGxMfOCksLOuLObWXxniXpvGS84ks7BIxFOjBxd6j_7kzHEc82xgfYSew2RmY3-zM_gbgOOBGahn7duCZwEZ_e2KHHpVYIdxNT5QjlaSzw5NpcDbjn-f-fAc2RezdAta3hnbUT2q2yIfXV6v3-MEjfh0KxDNvsx-X9RD9uh--rq5saihFideuu8Yu7KPTktTVYcL7BANOZR2LcS5t9IlizVz61-O2fdUNAHqzjvLusqjU6qfK8z-c1Pg-3OvQJRutzeEB7JjiIdyZdPnzR_DrQumMziHXjNyXZmXB0nxZLkpbm_J61RWws7aUa4GD1A2O9tNYU1525NasWtDzmprlVNPBUgy4UbxmWcHirKzqlU37FKZgk9H4y6d3TLEqy8uGtUy2j2E2Pv368czumjDYCfr6xtbSKBML6XOtQ65FoGSiVYIoINGem3ixCo3hPuWDHS9VsVReKLSX-LHmJnC49wT2irIwh8AS17hCGvxFGIfrRKkgdZST-gJvhmgxFrzZLHeUdAzl1CgjjzBSIdVEpJqoVY0Fr3rZas3LcavU0UZr0ca0Igz4EMMSrrLgZT-My0mpElWYctnKSOJUd4UFT9dK7l9DZ2-J1scCsaX-XoAYu7dHiux7y9wd-gLhqGPBcW8o_5j9s_-Y3nM4cKnKpt0UOoK9ZrE0LxAmNfEAdsVcDGD_w-n0_GLQmj9ezabno2-_AV_dHBY |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVqJcEG9SChhRDhxCs4nzMFKFCu1qS3dXqGql3oITOyJVmoRNVmWP_DF-GzPZJLQq6q3XeOQknrHnsz3zDcCWx7VQInJNz9Geif52YAYOhVgh3E0G0hJSUO7wZOqNTvjXU_d0Bf50uTAUVtmtic1CrYqYzsi3EaYj8iBv-Kn8aVLVKLpd7UpoyLa0gtppKMbaxI5DvbjALVy1c7CH-n5n28P94y8js60yYMbozGpTCS115AuXKxVw5XtSxErG6OZi5dixE8lAa-7ShaflJDIS0gl85cRupLj2LO5gv3dgjTtc4OZv7fP-9NtR5wvwj_3BkhTVR-S1nZ6dVx8QgVCB-ctu8Bq2vR6iuT7PS7m4kFl2yf8NH8D9Friy3aWlPYQVnT-Cu5P2av4x_D6SKqUU54qRZ1SsyFmSzYtZYSpd_Fq0sfGsiRKbYSMVmqOjOlYX5y1vNitn1F9dsYzCRViCe3kUr1iasygtymph0hGIztlkdzje-8gkK9OsqFlDkvsETm5l5J_Cal7k-jmw2Na2LzSuPtriKpbSSyxpJa6PDwM0RgPed8Mdxi35OdXgyELcBJFqQlJN2KjGgLe9bLmk_Piv1GantbCd9lX4z0gNeNM343DSLYzMdTFvZATRtdu-Ac-WSu5fQ2m9xBhkgH9F_b0AkYFfbcnTHw0peOD6iHQtA7Z6Q7nh6zdu_vrXsD46nozD8cH08AXcsymOpzl22oTVejbXLxGI1dGr1toZfL_tCfYXpiRPSg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIhUuiG8CBYwoBw5hs3ESx0gIVSyrlnYrhKi0t-DEjghKk7DJquyRv8WvYybJhlZFvfW6HiVZz9jzbD-_AdgJPCO1jH074CawMd-O7ZATxQrhbjpWjlSS7g7PjoK9Y-_T3J9vwJ_1XRiiVa7nxHai1mVCe-QjhOmIPCgbjtKeFvF5Mn1f_bSpghSdtK7LaXQhcmBWp7h8q9_tT9DXr1x3-vHrhz27rzBgJ5jIGltLo0wspO9pHXpaBEomWiWY4hLN3YTHKjTG8-mw0-GpiqXiodA88WPtmcDxOD73GlwXnEuiE4r5sNjD_yrGnRyqQMw1yn6c1G8Qe1Bp-bMJ8AKqvUjOvLEsKrU6VXl-JvNNb8OtHrKy3S7G7sCGKe7C1qw_lL8Hv78ondHl5ppRTtSsLFiaL8tFaWtT_lr1rHjW8sMW2Egl5miTjjXlSa-YzaoFPa-pWU5EEZbiKh7Na5YVLM7Kql7ZtPlhCjbbnR5O3jLFqiwvG9bK496H4yvp9wewWZSFeQQscY0rpMF5xzieTpQKUkc5qS_wxxDD0ILX6-6Okl72nKpv5BEuf8g1Ebkmal1jwcvBturEPv5rtb32WtQP-Dr6F54WvBiasTvp_EUVply2NpKE2l1hwcPOycNr6EIvaQVZIM65fzAgGfDzLUX2vZUDD32BGNexYGcIlEu-_vHlX_8ctnBYRYf7RwdP4KZLBJ52v2kbNpvF0jxFBNbEz9pQZ_DtqsfWX6QuTOQ |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrQRceD8CBRm1Fw7ZZhMnjrmtKKsKsRVCrFROkWM7IpAm0SYBlRv_nJkku2opAq7xKLEyY89nz8w3AAcRt9LINHSjwEYu-tuZGweUYoVwN5spTypJtcPLk-h4xd-ehqc7sL-phaG0SnQDuP33Yfxvs7jGLZZPa5Ndg90oRMA9gd3Vyfv5p75uiEsXXZoYiEcFopvD_MtZM0UvT03cL7qaK_jxahrkja6s1fl3VRQXfMziNhxtZjeklnyddm061T9-I278x_TvwK0RY7L5YBR3YceW9-D6coyi34efH5TJqRq5YeTEDKtKlhVdta5cY_HTYxo76xO61jhIPeHoVo211dlIcc3qNb2vbVhBmR0sw2M3ijcsL1maV3Vz7tJthS3Zcr54d_SKKVbnRdWyns_2AawWbz6-PnbHVgyuRo_fukZaZVMhQ25MzI2IlNRGacQC2gS-DlIVW8tDigp7QaZSqYJYmECHqeE28njwECZlVdrHwLRvfSEtbhTW40YrFWWe8rJQ4MMY7caBlxutJXrkKad2GUWC5xXScEIaTnoNO7C_la0Hdo4_Su1tlJ-MK7RJ8NiHSJbQlQMvtsP4Oylgokpbdb2MJGZ1XzjwaLCV7WeoApfIfRwQl6xoK0C83ZdHyvxzz98dhwJBqefAwdbe_jL7J_8n9hRu-pRu098O7cGkXXf2GeKlNn0-rpdfMfkcEg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiomics+based+on+fluoro-deoxyglucose+positron+emission+tomography+predicts+liver+fibrosis+in+biopsy-proven+MAFLD%3A+a+pilot+study&rft.jtitle=International+journal+of+medical+sciences&rft.au=Chen%2C+Zhong-Wei&rft.au=Tang%2C+Kun&rft.au=Zhao%2C+You-Fan&rft.au=Chen%2C+Yang-Zong&rft.date=2021-01-01&rft.issn=1449-1907&rft.eissn=1449-1907&rft.volume=18&rft.issue=16&rft.spage=3624&rft_id=info:doi/10.7150%2Fijms.64458&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1449-1907&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1449-1907&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1449-1907&client=summon |